General Atlantic, L.p.

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
15
Total Value
2979034194
Accession Number
0000950142-25-001365
Form Type
13F-HR
Manager Name
General Atlantic, L.p.
Data Enrichment
93% identified
14 identified1 unidentified

Holdings

15 positions
Manager:
Search and click to pin securities to the top
Alignment Healthcare, Inc.
Shares:
60993323(+0.0%)
Value:
$1.1T(+65.5%)
dLocal Ltd
Shares:
63906695(+0.0%)
Value:
$533.0B(-25.9%)
XP Inc.
Shares:
29617733(+0.0%)
Value:
$407.2B(+16.0%)
ALKAMI TECHNOLOGY, INC.
Shares:
9645318(+0.0%)
Value:
$253.2B(-28.4%)
Akero Therapeutics, Inc.
Shares:
5233989(+0.0%)
Value:
$211.9B(+45.5%)
Centessa Pharmaceuticals plc
Shares:
9681818(+0.0%)
Value:
$139.2B(-14.1%)
Pharvaris N.V.
Shares:
7531252(+0.0%)
Value:
$118.2B(-18.1%)
European Wax Center, Inc.
Shares:
13110492(+0.0%)
Value:
$51.8B(-40.8%)
Royalty Pharma plc
Shares:
1500000(+0.0%)
Value:
$46.7B(+22.0%)
Immunocore Holdings plc
Shares:
1261684(+0.0%)
Value:
$37.4B(+0.6%)
RISKIFIED LTD.
Shares:
5324998(+0.0%)
Value:
$24.6B(-2.3%)
ACELYRIN, Inc.
Shares:
2695327(+0.0%)
Value:
$6.7B(-21.3%)
Adagene Inc.
Shares:
3825952(+0.0%)
Value:
$5.8B(-23.6%)
21077C305
Shares:
609616(+0.0%)
Value:
$4.3B(-0.7%)
Grove Collaborative Holdings, Inc.
Shares:
2474859(+0.0%)
Value:
$3.3B(-2.9%)